TOP25 728X90
SEARCH RESULTS FOR: "Tag: alt"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2023(1)
2022(1)
2021(2)
CATEGORIES
5-Minute Market Rundown(1)
Buzz Stocks(2)
Intraday Option Activity(1)

12/7/2023 2:05 PM
Options traders are targeting Altimmune Inc (NASDAQ:ALT), as the stock shoots for its 11th-straight win. CEO Vipin Garg told Reuters on Tuesday that the weight-loss drug developer is open to deals wi...
12/21/2022 2:30 PM
Altimmune Inc (NASDAQ:ALT) and SINTX Technologies Inc (NASDAQ:SINT) are trending today. The former announced its experimental drug to treat nonalcoholic fatty liver disease (NAFLD) patients met th...
7/2/2021 3:24 PM
Wall Street crossed over into the second half of the year, as well as a new month and quarter this week, and the transition was a seamless one. All three major indexes exhibited mostly positive pri...
6/30/2021 9:54 AM
Altimmune Inc (NASDAQ:ALT) is already taking its place as one of the worst performing stocks on the Nasdaq today, down 30.8% at $11 this morning, following news that the company dropped the developmen...
 

 

(function(doc, script) { var js, fjs = doc.getElementsByTagName(script)[0], frag = doc.createDocumentFragment(), add = function(url, id) { if (doc.getElementById(id)) {return;} js = doc.createElement(script); js.src = url; id && (js.id = id); frag.appendChild( js ); }; // Google+ button //add('https://apis.google.com/js/platform.js', async="defer"); // Facebook SDK add('//connect.facebook.net/en_US/all.js#xfbml=1&appId=772755279557744', 'facebook-jssdk'); // Twitter SDK //add('//platform.twitter.com/widgets.js', charset='utf-8'); fjs.parentNode.insertBefore(frag, fjs); }(document, 'script'));